News Announcement

Thyrocare Technologies: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.

There could be last minute change in the names of Analysts or in the timings

Please also note that no unpublished Price-Sensitive Information will be shared during the meetings.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.